Total Assets
Breakdown
Segments
Capitated accounts receivableView metric
FFS accounts receivableView metric
IV drug inventoryView metric
Other assetsView metric
Oral drug accounts receivableView metric
Oral drug inventoryView metric
| Segment | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|
| Other assets | $36.24M | $30.09M | $33.75M | $35.35M | $28.42M | $42.77M |
| FFS accounts receivable | $26.53M | $28.59M | $31.9M | $35.34M | $35.38M | $33.64M |
| IV drug inventory | $6.56M | $6.52M | $7.29M | $7.61M | $8.08M | $13.55M |
| Oral drug inventory | $3.48M | $5.79M | $8.5M | $11.27M | $8.8M | $10.75M |
| Oral drug accounts receivable | $6.37M | $7.62M | $11.26M | $8.85M | $7.46M | $10M |
| Capitated accounts receivable | $3.7M | $3.88M | $2.27M | $2.9M | $3.21M | $1.57M |
| Total | $172.72M | $164M | $159.8M | $163.62M | $164.66M | $168.23M |